BICYCLE THERAPEUTICS PLC

BCYC

BICYCLE THERAPEUTICS PLC

BCYC

Insider Sentiment (TTM):

Last Purchase:2024-12-16Last Sale:2026-04-06Shares Purchased (TTM):0Shares Sold (TTM):34,371

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:33,973,645Shares Outstanding:69,683,471Institutional Ownership Pct.:48.75%

Earnings Market Reaction:

Filing Date:2026-04-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	559	628	648	721	793	880	891	961	457	526	572	340
Accounts Receivable Net Current	-	-	-	-	0	-	-	0	-	0	0	45
Prepaid Expense And Other Assets Current	19	19	23	22	17	13	17	20	20	11	14	10
Assets Current	619	683	739	804	856	929	966	1,028	516	562	603	408
Property Plant And Equipment Net	6	6	7	8	9	10	12	12	13	15	16	18
Operating Lease Right Of Use Asset	15	16	5	6	7	8	9	11	12	13	15	16
Other Assets Noncurrent	13	13	14	14	12	11	10	7	6	6	5	12
Assets	652	718	764	832	884	957	997	1,057	547	595	639	454
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	6	10	13	18	11	16	6	7	7	13	8	5
Accrued Liabilities Current	40	44	44	45	34	41	39	28	26	32	34	37
Deferred Revenue Current	3	3	12	15	13	10	11	12	16	25	27	30
Long Term Debt Current	-	-	-	-	-	-	-	22	-	-	-	-
Liabilities Current	49	57	69	77	58	67	56	70	50	70	70	72
Long Term Debt Noncurrent	-	-	-	-	-	-	-	9	31	31	31	31
Operating Lease Liability Noncurrent	14	14	1	2	3	4	6	7	8	9	10	12
Deferred Revenue Noncurrent	34	36	74	83	82	91	98	94	98	110	108	115
Other Liabilities Noncurrent	1	1	1	1	1	1	6	5	5	5	4	4
Liabilities	98	108	145	163	144	164	166	184	191	224	223	234
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	0
Additional Paid In Capital	1,519	1,512	1,501	1,492	1,482	1,473	1,462	1,452	895	883	875	633
Accumulated Other Comprehensive Income Loss Net Of…	-5	-4	-3	-3	-1	0	-3	-1	-1	-1	3	-1
Retained Earnings Accumulated Deficit	-961	-900	-880	-820	-742	-681	-629	-578	-538	-512	-463	-413
Stockholders Equity	554	610	618	669	740	793	831	874	356	371	416	220
Liabilities And Stockholders Equity	652	718	764	832	884	957	997	1,057	547	595	639	454
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	163	160	160	160	159	156	156	154	186	179	179	179
Common Stock Shares Issued	70	69	69	69	69	69	69	69	85	85	85	92
Shares Outstanding	70	69	69	69	69	69	69	69	85	85	85	92

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.60%	-15.25%	-	-	-	-	-	-	-	-	-	-
2025	-11.34%	-18.28%	-5.73%	-3.53%	-3.27%	3.01%	-27.85%	-21.58%	-25.68%	-2.56%	-5.13%	-17.16%
2024	-6.72%	-16.85%	-9.56%	-11.81%	-4.80%	1.44%	-12.39%	-37.39%	-43.10%	-18.20%	-33.42%	-27.03%
2023	15.89%	21.05%	21.53%	1.43%	-13.18%	-26.02%	-7.18%	25.22%	19.05%	4.72%	-1.72%	0.88%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	12.66	11.98	10.66	10.39	14.86	13.81	17.13	14.77	10.42	8.08	8.65	5.65
Quick Ratio	12.28	11.65	10.33	10.10	14.57	13.61	16.82	14.48	10.02	7.92	8.45	5.51
Working Capital	570.25M	625.90M	669.54M	726.84M	798.46M	861.38M	909.79M	958.65M	466.45M	492.33M	533.30M	336.16M
Leverage & Debt
Debt to Equity	0.18	0.18	0.24	0.24	0.19	0.21	0.20	0.21	0.54	0.60	0.54	1.06
Interest Coverage TTM	-1,193.81	-1,199.34	-1,442.89	-1,517.45	-258.71	-121.31	-78.64	-55.93	-54.90	-58.21	-51.37	-44.89
Debt Ratio	0.15	0.15	0.19	0.20	0.16	0.17	0.17	0.17	0.35	0.38	0.35	0.52
Efficiency & Turnover
Asset Turnover TTM	0.08	0.09	0.03	0.02	0.04	0.05	0.05	0.05	0.09	0.05	0.05	0.05
Days Sales Outstanding TTM	-	-	-	-	1.93	-	-	209.01	-	-	-	446.48
Receivables Turnover TTM	-	-	-	-	189.13	-	-	1.75	-	-	-	0.82
Per Share Metrics
Diluted EPS TTM	-3.14	-3.16	-3.62	-3.50	-2.94	-2.90	-2.41	-3.18	-3.95	-5.08	-4.08	-4.64
Free Cash Flow Per Share TTM	-3.32	-3.64	-3.49	-3.04	-2.63	-2.85	-2.95	-3.17	-2.02	-1.79	-1.21	-1.83
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	107.87%	112.10%	113.17%	114.53%
Operating Profit Margin TTM	-381.67%	-340.38%	-1,023.40%	-1,495.33%	-965.55%	-594.96%	-532.40%	-463.42%	-432.25%	-704.13%	-676.29%	-652.30%
Net Profit Margin TTM	-344.95%	-301.66%	-884.51%	-1,257.00%	-790.07%	-479.18%	-450.64%	-417.88%	-404.14%	-669.72%	-650.60%	-621.69%
Growth Metrics
Net Revenue Growth (1Y)	146.85%	105.77%	-23.20%	-51.28%	-38.18%	30.76%	48.60%	75.74%	168.47%	86.52%	64.99%	37.79%
Net Income Growth (1Y)	7.78%	29.54%	50.75%	46.56%	20.85%	-6.44%	2.93%	18.13%	35.38%	60.28%	60.30%	60.71%
EPS Growth (1Y)	7.03%	8.84%	50.06%	10.03%	-25.67%	-42.79%	-40.95%	-31.40%	-4.57%	33.57%	20.20%	57.82%
Valuation Metrics
P/E TTM	-1.48	-2.24	-2.14	-1.99	-2.89	-4.82	-9.39	-6.36	-6.30	-3.56	-4.92	-5.50
P/B TTM	0.58	0.80	0.87	0.72	0.79	1.03	1.88	1.20	2.98	1.73	1.91	3.50
P/S TTM	5.09	6.76	18.93	24.96	22.84	23.10	42.31	26.59	25.47	23.85	32.02	34.22
Market Cap	323.33M	490.50M	536.41M	481.30M	587.48M	814.91M	1.56B	1.05B	1.06B	643.51M	795.09M	770.49M
Enterprise Value	-236.75M	-138.21M	-112.46M	-240.70M	-206.04M	-65.16M	669.81M	121.32M	633.00M	147.24M	253.06M	460.57M
Calculated Values
Free Cash Flow TTM	-231.69M	-252.03M	-241.87M	-210.29M	-182.05M	-165.96M	-203.53M	-164.79M	-85.93M	-63.56M	-47.98M	-55.30M
Net Debt	-560.08M	-628.72M	-648.87M	-722.00M	-793.52M	-880.07M	-891.41M	-931.00M	-426.74M	-496.27M	-542.03M	-309.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-06Sale

Owner: Thompson, Travis Alvin

Title: Chief Financial Officer

Shares: 102

Price/Share: $5.05

Value: $515.10

Shares Owned: 65,364

Relationship: Officer

Ownership: Direct

2026-04-06Sale

Owner: Skynner, Michael

Title: CHIEF SCIENTIFIC OFFICER

Shares: 525

Price/Share: $5.05

Value: $2,651.25

Shares Owned: 159,562

Relationship: Officer

Ownership: Direct

2026-04-06Sale

Owner: Hannay, Michael Charles F…

Title: CHIEF PROD & SUPPLY CHAIN OFF

Shares: 251

Price/Share: $5.05

Value: $1,267.55

Shares Owned: 96,136

Relationship: Officer

Ownership: Direct

2026-04-06Sale

Owner: Lee, Kevin

Title: CHIEF EXECUTIVE OFFICER

Shares: 1,716

Price/Share: $5.05

Value: $8,665.80

Shares Owned: 611,313

Relationship: Director,Officer

Ownership: Direct

2026-04-06Sale

Owner: Perry, Jennifer Scott

Title: Chief Operating Officer

Shares: 370

Price/Share: $5.04

Value: $1,864.80

Shares Owned: 92,464

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-06	Thompson, Travis Alvin	Officer	Chief Financial Officer	Direct	Sale	102	5.05	$515.10	65,364	4
2026-04-06	Skynner, Michael	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	525	5.05	$2,651.25	159,562	4
2026-04-06	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	251	5.05	$1,267.55	96,136	4
2026-04-06	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	1,716	5.05	$8,665.80	611,313	4
2026-04-06	Perry, Jennifer Scott	Officer	Chief Operating Officer	Direct	Sale	370	5.04	$1,864.80	92,464	4
2026-01-05	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	1,115	6.45	$7,191.75	66,265	4
2026-01-05	Young, Alethia	Officer	Chief Financial Officer	Direct	Sale	4,334	6.50	$28,171.00	87,081	4
2026-01-05	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,416	6.46	$22,067.36	136,717	4
2026-01-05	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	3,266	6.46	$21,098.36	161,966	4
2026-01-02	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	2,827	6.80	$19,223.60	100,275	4
2026-01-02	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	10,325	6.80	$70,210.00	629,985	4
2025-10-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,231	8.41	$27,172.71	475,310	4
2025-10-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	250	8.41	$2,102.50	53,102	4
2025-10-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	978	8.41	$8,224.98	118,277	4
2025-10-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	978	8.41	$8,224.98	93,377	4
2025-10-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	103	8.41	$866.23	31,197	4
2025-10-02	Swanton, Robert Charles	Director	-	Direct	Sale	102	8.55	$872.10	15,487	4
2025-10-02	Young, Alethia	Officer	Chief Financial Officer	Direct	Sale	482	8.50	$4,097.00	44,704	4
2025-07-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	248	7.44	$1,845.12	53,825	4
2025-07-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	100	7.44	$744.00	31,521	4
2025-07-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	966	7.44	$7,187.04	95,502	4
2025-07-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	966	7.44	$7,187.04	120,079	4
2025-07-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,193	7.44	$23,755.92	480,804	4
2025-07-02	Young, Alethia	Officer	Chief Financial Officer	Direct	Sale	204	7.09	$1,446.36	45,186	4
2025-04-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	1,038	7.48	$7,764.24	121,870	4
2025-04-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	1,038	7.48	$7,764.24	97,617	4
2025-04-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,432	7.48	$25,671.36	486,265	4
2025-04-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	266	7.48	$1,989.68	54,547	4
2025-04-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	109	7.48	$815.32	31,827	4
2025-04-02	Young, Alethia	Officer	Chief Financial Officer	Direct	Sale	215	8.02	$1,724.30	45,390	4
2025-01-06	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	2,686	15.00	$40,290.00	32,146	4
2025-01-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,092	14.75	$45,607.00	491,934	4
2025-01-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	936	14.75	$13,806.00	99,788	4
2025-01-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	936	14.75	$13,806.00	123,722	4
2025-01-03	Crockett, Nigel	Officer	CHIEF BUSINESS OFFICER	Direct	Sale	936	14.75	$13,806.00	51,053	4
2025-01-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	239	14.75	$3,525.25	55,280	4
2025-01-02	Young, Alethia	Officer	Chief Financial Officer	Direct	Sale	1,395	14.09	$19,655.55	45,605	4
2025-01-02	Arroyo, Santiago	Officer	CHIEF DEVELOPMENT OFFICER	Direct	Sale	4,943	14.09	$69,646.87	69,057	4
2024-12-16	Baker, Bros. Advisors (Gp…	Director,TenPercentOwner	-	Indirect	Purchase	500,000	15.34	$7,670,000.00	9,995,274	4
2024-11-11	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	6,256	24.98	$156,274.88	19,241	4
2024-10-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	153	22.26	$3,405.78	22,922	4
2024-10-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	972	22.26	$21,636.72	92,945	4
2024-10-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	972	22.26	$21,636.72	70,302	4
2024-10-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	247	22.26	$5,498.22	22,398	4
2024-10-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,212	22.26	$71,499.12	380,864	4
2024-10-03	Crockett, Nigel	Officer	CHIEF BUSINESS OFFICER	Direct	Sale	972	22.26	$21,636.72	45,822	4
2024-07-03	Keen, Nicholas	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	779	19.64	$15,299.56	62,024	4
2024-07-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	967	19.64	$18,991.88	93,917	4
2024-07-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	967	19.64	$18,991.88	71,274	4
2024-07-03	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	246	19.64	$4,831.44	22,645	4
2024-07-03	Crockett, Nigel	Officer	CHIEF BUSINESS OFFICER	Direct	Sale	967	19.64	$18,991.88	46,794	4
2024-07-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,194	19.64	$62,730.16	384,076	4
2024-07-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	148	19.64	$2,906.72	23,075	4
2024-04-11	Hannay, Michael Charles F…	Officer	CHIEF PROD & SUPPLY CHAIN OFF	Direct	Sale	257	22.49	$5,779.93	22,891	4
2024-04-03	Keen, Nicholas	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	790	23.81	$18,809.90	62,803	4
2024-04-03	Milnes, Alistair	Officer	CHIEF OPERATING OFFICER	Direct	Sale	955	23.81	$22,738.55	72,241	4
2024-04-03	Skynner, Michael	Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	955	23.81	$22,738.55	94,884	4
2024-04-03	Lee, Kevin	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	3,158	23.81	$75,191.98	387,270	4
2024-04-03	Thompson, Travis Alvin	Officer	CHIEF ACCOUNTING OFFICER	Direct	Sale	152	23.81	$3,619.12	23,223	4
2024-04-03	Crockett, Nigel	Officer	CHIEF BUSINESS OFFICER	Direct	Sale	955	23.81	$22,738.55	47,761	4
2024-01-03	Lee, Kevin	Director,Officer	Chief Executive Officer	Direct	Sale	8,703	17.50	$152,302.50	390,428	4
2024-01-03	Milnes, Alistair	Officer	Chief Operating Officer	Direct	Sale	2,643	17.50	$46,252.50	73,196	4
2024-01-03	Thompson, Travis Alvin	Officer	Chief Accounting Officer	Direct	Sale	604	17.50	$10,570.00	23,375	4
2024-01-03	Crockett, Nigel	Officer	Chief Business Officer	Direct	Sale	2,643	17.50	$46,252.50	48,716	4
2024-01-03	Skynner, Michael	Officer	Chief Technology Officer	Direct	Sale	2,643	17.50	$46,252.50	95,839	4
2024-01-03	Keen, Nicholas	Officer	Chief Scientific Officer	Direct	Sale	2,640	17.50	$46,200.00	63,593	4
2023-10-03	Milnes, Alistair	Officer	Chief Operating Officer	Direct	Sale	442	20.00	$8,840.00	36,839	4
2023-10-03	Lee, Kevin	Director,Officer	Chief Executive Officer	Direct	Sale	1,470	20.00	$29,400.00	322,131	4
2023-10-03	Thompson, Travis Alvin	Officer	Chief Accounting Officer	Direct	Sale	54	20.00	$1,080.00	7,979	4
2023-10-03	Skynner, Michael	Officer	Chief Technology Officer	Direct	Sale	442	20.00	$8,840.00	70,482	4
2023-10-03	Keen, Nicholas	Officer	Chief Scientific Officer	Direct	Sale	272	20.00	$5,440.00	38,233	4
2023-10-03	Crockett, Nigel	Officer	Chief Business Officer	Direct	Sale	442	20.00	$8,840.00	29,359	4
2023-07-03	Lee, Kevin	Director,Officer	Chief Executive Officer	Direct	Sale	1,498	25.10	$37,599.80	323,601	4
2023-07-03	Crockett, Nigel	Officer	Chief Business Officer	Direct	Sale	451	25.10	$11,320.10	29,801	4
2023-07-03	Keen, Nicholas	Officer	Chief Scientific Officer	Direct	Sale	336	25.10	$8,433.60	38,505	4
2023-07-03	Milnes, Alistair	Officer	Chief Operating Officer	Direct	Sale	451	25.10	$11,320.10	37,281	4
2023-07-03	Skynner, Michael	Officer	Chief Technology Officer	Direct	Sale	451	25.10	$11,320.10	70,924	4
2023-07-03	Thompson, Travis Alvin	Officer	Chief Accounting Officer	Direct	Sale	61	25.10	$1,531.10	8,033	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

48.75%

Inst. Shares: 33,973,645

Shares Outstanding: 69,683,471

2025-12-31

51.20%

Inst. Shares: 35,468,035

Shares Outstanding: 69,279,838

2025-09-30

49.02%

Inst. Shares: 33,971,240

Shares Outstanding: 69,303,746

2025-06-30

52.53%

Inst. Shares: 36,377,698

Shares Outstanding: 69,252,009

2025-03-31

52.50%

Inst. Shares: 36,330,227

Shares Outstanding: 69,196,945

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	33,973,645	69,683,471	48.75%
2025-12-31	35,468,035	69,279,838	51.20%
2025-09-30	33,971,240	69,303,746	49.02%
2025-06-30	36,377,698	69,252,009	52.53%
2025-03-31	36,330,227	69,196,945	52.50%
2024-12-31	36,014,788	58,207,593	61.87%
2024-09-30	32,335,919	68,988,858	46.87%
2024-06-30	32,373,361	51,992,034	62.27%
2024-03-31	25,395,406	42,560,091	59.67%
2023-12-31	26,536,720	35,592,362	74.56%
2023-09-30	28,140,158	39,576,467	71.10%
2023-06-30	21,581,491	30,191,693	71.48%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BICYCLE THERAPEUTICS PLC (BCYC) — SEC Financial Statements & Analysis

BICYCLE THERAPEUTICS PLC (BCYC) is a pharmaceutical preparations company, incorporated in X0. BICYCLE THERAPEUTICS PLC trades on Nasdaq as: BCYC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BICYCLE THERAPEUTICS PLC reported a 146.85% year-over-year revenue growth, a Gross Profit Margin of 107.87% (TTM), a Debt-to-Equity ratio of 0.18x, a Price-to-Sales (P/S) ratio of 5.09x (TTM), a Price-to-Book (P/B) ratio of 0.58 (TTM), at a market cap of $323.33M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 146.85%
Gross Profit Margin TTM: 107.87%
Debt To Equity: 0.18x
P/S TTM: 5.09x
P/B TTM: 0.58
Market Cap: $323.33M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BICYCLE THERAPEUTICS PLC in?

BICYCLE THERAPEUTICS PLC (BCYC) operates in the Pharmaceutical Preparations industry.

What is BCYC's market cap?

BICYCLE THERAPEUTICS PLC (BCYC) has a market capitalization of $323.33M as of 2026-03-31.

What exchange does BCYC trade on?

BICYCLE THERAPEUTICS PLC (BCYC) trades on the Nasdaq.

Where is BICYCLE THERAPEUTICS PLC incorporated?

BICYCLE THERAPEUTICS PLC is incorporated in United Kingdom.

BICYCLE THERAPEUTICS PLC (BCYC) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.